These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33497862)

  • 1. LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.
    Vallejo-Vaz AJ; Packard CJ; Ference BA; Santos RD; Kastelein JJP; Stein EA; Catapano AL; Pedersen TR; Watts GF; Ray KK
    Atherosclerosis; 2021 Mar; 320():1-9. PubMed ID: 33497862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab.
    Ridker PM; Rose LM; Kastelein JJP; Santos RD; Wei C; Revkin J; Yunis C; Tardif JC; Shear CL;
    J Clin Lipidol; 2018; 12(4):958-965. PubMed ID: 29685591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia. The examination of probands and relatives in Statin studies with familial hypercholesterolemia (ExPRESS FH).
    de Sauvage Nolting PR; Buirma RJ; Hutten BA; Kastelein JJ;
    Atherosclerosis; 2002 Oct; 164(2):347-54. PubMed ID: 12204807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
    Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
    Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a).
    Schwarz A; Demuth I; Landmesser U; Haghikia A; König M; Steinhagen-Thiessen E
    Lipids Health Dis; 2022 Nov; 21(1):114. PubMed ID: 36324160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic health records to facilitate continuous detection of familial hypercholesterolemia.
    Pepplinkhuizen S; Ibrahim S; Vink R; Groot B; Stroes ESG; Bax WA; Cornel JH
    Atherosclerosis; 2020 Oct; 310():83-87. PubMed ID: 32927124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
    Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
    Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
    J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.